Scientist Eric Cantekin worked with fellow researcher Dr. Charles Bluestone on a study that compared the effectiveness of antibiotics in fighting ear infections. Bluestone financed the study by appealing to various pharmaceutical companies. Cantekin claims that the study was altered so that the results would be favorable to the pharmaceutical industry; Bluestone denied it. Now, however, there is some evidence to support Cantekin; The Wall Street Journal examines the controversy.
This file is not available for digital download. IRE members may place an order by emailing email@example.com